Skip to main content
Download PDF

Associations and gastrointestinal symptoms in women with endometriosis in comparison to women with irritable bowel syndrome: a study based on a population cohort

BMC Gastroenterology volume 23, Article number: 228 (2023) Cite this article

Abstract

Background

Endometriosis and irritable bowel syndrome (IBS) have similar symptoms, pathogenesis, and risk factors. These diagnoses often coexist and are frequently misdiagnosed leading to diagnostic delays. This study of a population-based cohort aimed to investigate associations relating to endometriosis and IBS and to compare gastrointestinal symptoms between endometriosis and IBS.

Method

The study cohort included women from the Malmö Offspring Study with information about endometriosis and IBS diagnoses from the National Board of Health and Welfare. The participants answered a questionnaire about lifestyle habits, medical and drug history, and self-reported IBS. The visual analog scale for IBS was used to estimate gastrointestinal symptoms the past 2 weeks. Endometriosis diagnosis and self-reported IBS were used as dependent variables to study associations with age, body mass index (BMI), education, occupation, marital status, smoking, alcohol habits, and physical activity using logistic regression. Mann-Whitney U Test or Kruskal-Wallis tests were used to calculate the differences in symptoms between groups.

Results

Of the 2,200 women with information from medical records, 72 participants had endometriosis; 21 (29.2%) of these had self-reported IBS. Of the 1,915 participants who had answered the questionnaire, 436 (22.8%) had self-reported IBS. Endometriosis was associated with IBS (OR:1.86; 95%CI:1.06–3.26; p = 0.029), as well as with age 50–59 years (OR:6.92; 95%CI:1.97–24.32; p = 0.003), age ≥ 60 years (OR:6.27; 95%CI:1.56–25.17; p = 0.010), sick leave (OR:2.43; 95%CI:1.08–5.48; p = 0.033), and former smoking (OR:3.02; 95%CI:1.19–7.68; p = 0.020). There was an inverse association with BMI (OR:0.36; 95%CI:0.14–4.91; p = 0.031). IBS was associated with endometriosis (OR:1.77; 95%CI:1.02–3.07; p = 0.041) and sick leave (OR:1.77; 95%CI:1.14–2.73; p = 0.010), with a tendency to association with smoking (OR:1.30; 95%CI:0.98–1.72; p = 0.071). When excluding participants using drugs associated with IBS, the condition was associated with current smoking (OR:1.39; 95%CI:1.03–1.89; p = 0.033) and inversely with age 50–59 years (OR:0.58; 95%CI:0.38–0.90; p = 0.015). There were differences in the gastrointestinal symptoms between IBS and healthy participants, but not between endometriosis and IBS or healthy participants.

Conclusion

There were associations between endometriosis and IBS, without differences in gastrointestinal symptoms. Both IBS and endometriosis were associated with smoking and sick leave. Whether the associations reflect causality or depend on common risk factors and pathogenesis remains to be determined.

Peer Review reports

Background

Endometriosis is a chronic inflammatory and progressive disease that affects women in their reproductive years [1, 2]. The disease is characterized by endometrial-like tissue outside the uterus [1]. Endometriosis can be found in different locations, most commonly in pelvic structures such as the pelvic peritoneum and the ovary but can also, in unusual cases, be found in the lung, liver, pancreas, and operative scars [3]. The prevalence of endometriosis varies in different studies and depends on diagnostic methods. The prevalence of endometriosis is estimated to be 6–10% in the general population, and 35–50% in women with pain, infertility, or both [4]. The golden standard for endometriosis diagnosis is laparoscopy with histopathological confirmation [3, 5].

Irritable bowel syndrome (IBS) is a disease of the gut-brain interaction (DGBI) with a global prevalence of 1–25% and a pooled prevalence of 3.8%, most frequently found in women [6]. In secondary care, the prevalence of these disorders constitutes 35% of all patients; IBS being the most common [7]. IBS develops no objective findings, making the diagnosis symptom-based using the Rome IV criteria [8].

In both endometriosis and IBS, inflammation with elevated pro-inflammatory cytokine and visceral hypersensitivity are parts of the pathophysiological mechanisms [9,10,11]. A diet with low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) has been found to have a positive effect on both women with IBS and endometriosis, which supports the thesis of similar pathophysiology [12]. Other similarities are hormonal links [10] and being most common in women under the age of 50 years [13, 14], as well as associations with impaired psychological well-being [15, 16]. Consequently, there is a two- to threefold increased risk for an endometriosis patient to also get the diagnosis of IBS [9, 10, 17]. In a cross-sectional study with endometriosis patients recruited at a tertiary center, the disease was inversely associated with alcohol intake, physical activity, and BMI compared with controls from the general population [18]. On the other hand, self-reported IBS in women from the general population was associated with former smoking [19].

With no simple or cost-effective method to diagnose endometriosis, and since women with endometriosis may fulfill the Rome criteria, endometriosis is often misdiagnosed as IBS [9, 10, 17]. Endometriosis and IBS are treated in different ways, and the delay of the correct diagnosis may lead to unnecessary suffering and a poorer prognosis [9, 10, 17]. Untreated endometriosis may lead to infertility or subfertility [12, 20], while treating IBS with gestagen hormones may increase symptoms of bloating [21]. More knowledge about the character of gastrointestinal symptoms could possibly help women to receive the accurate diagnosis and treatment with a shortened delay. When comparing endometriosis and IBS from two cohorts recruited at a tertiary hospital, IBS patients had more severe gastrointestinal symptoms, except for constipation, and worse psychological well-being [22], and almost half of the endometriosis patients could differ between pain symptoms from endometriosis and from the gastrointestinal tract [23]. Taking all aspects together, the hypothesis was that there could be clinical differences between endometriosis and IBS. The current study with participants from the general population aimed to (1) explore associations of sociodemographic and lifestyle habits between endometriosis and IBS and (2) compare gastrointestinal symptoms and psychological well-being between endometriosis and IBS.

Methods

Malmö offspring study – study participants

The Malmö Diet Cancer Study (MDCS) is constituted of 28,098 middle-aged individuals, born between 1923 and 1950, and living in Malmö between 1991 and 1996. From this cohort, subjects were randomly selected for a re-evaluation and constitute the Malmö Diet Cancer Study-Cardiovascular Cohort (MDCS-CC) (n = 6,103). The Malmö Offspring Study (MOS) started in 2013 and included adult children and grandchildren of participants from MDCS-CC. MOS included a web-based questionnaire; dietary registrations; samples from blood, urine, and saliva; cognitive testing; and technical tests, measuring glucose metabolism and cardiovascular- and respiratory function. MOS included a total of 5,277 individuals. In this study, only the web-based questionnaire was used [24].

Questionnaires

Study questionnaire

The MOS web-based questionnaire included questions about living conditions, family connection, education, and profession. Self-perceived health, experience of stress, sleeping habits, medical history, family disease history, medication, and women’s reproductive health were considered. Lifestyle habits in the form of tobacco use, alcohol use, and physical activity were reported [24]. The IBS diagnosis was based on the question “Have you several times a month been bothered by abdominal pain and irregular bowel habits, also called IBS? “ The diagnosis IBS was given if the participants answered yes to the question, which reflects IBS according to the Rome III criteria [25].

The visual analog scale for irritable bowel syndrome

The web-based questionnaire asked the question: “Have you experienced any gastrointestinal symptoms in the past 2 weeks?” If the participants answered yes, they were encouraged to continue with the visual analog scale for irritable bowel syndrome (VAS-IBS), which contains seven questions for rating abdominal pain, diarrhea, constipation, bloating and flatulence, vomiting and nausea, intestinal symptoms’ influence on daily life, and psychological well-being. The questions estimate the gastrointestinal symptoms from 0 to 100 mm on a visual analog scale (VAS) where 0 means no and 100 means maximal symptoms. The VAS scales were inverted from the original version [26]. Reference values for healthy women are available [27].

Diagnosis collection

Information about the included participants’ diagnoses, endometriosis and IBS, was obtained from the National Patient Register, requested from the National Board of Health and Welfare regarding all inpatient care. Information from specialized outpatient care between 1973 and 2000 was requested from the medical records of Region Skåne, and after 2001 information was requested from the National Board of Health and Welfare.

Data categorization and modification

Age and body mass index (BMI) were not normally distributed and therefore had to be categorized. Age was sorted into < 30, 30–39, 40–49, 50–59, and ≥ 60 years. BMI was classified into < 25, 25–30, and ≥ 30 kg/m2 according to the World Health Organization (WHO) standard [28]. Education was grouped into primary school, secondary school, and higher education. The occupation was sorted into working, retired, sick leave, studying, unemployed, and other. Marital status was divided into living alone, living together, and other. Smoking was grouped into never, former, and present smoking. Alcohol habits were sorted based on drinking frequency (≤ 1 time/month, 2–4 times/month, 2–3 times/week, and ≥ 4 times/week) and the amount in glasses per occasion (1–2, 3–4, 5–6, and ≥ 7 glasses). Physical activity at work was grouped into light (sitting or standing), intermediate (walking and lifting < 5 kg), and hard (increased breathing). Physical activity in leisure time was sorted into sedentary (< 120 min per week, without sweating), moderate (move around ≥ 120 min per week, without sweating), moderate but regularly (≥ 30 min per week, sweating), and regularly (≥ 90 min per week, sweating).

The international classification ATC-system (Anatomic Therapeutic Chemical classification system) established by WHO was used for drug categorization [29]. The drugs examined in this study were those previously found to be associated with IBS [30], and included beta-blocking agents (propranolol, metoprolol, atenolol, and bisoprolol), hypnotics and sedatives (zopiclone, zolpidem, and propiomazine), and antihistamines for systemic use (clemastine, alimemazine, promethazine, cetirizine, loratadine, ebastine, fexofenadine, and desloratadine).

Statistical analysis

The data were analyzed using the statistical software package SPSS, version 28, data for Windows. The variables were not normally distributed and therefore the non-parametric tests Mann-Whitney U test or Kruskal-Wallis test were used to calculate differences between groups. The chi2 test was used for categorical variables. The binary logistic regression model was used to estimate associations. Endometriosis or IBS were used as dependent variables to estimate odds ratios (OR) and 95% confidence intervals (CI) for the independent variables age, BMI, education, occupation, marital status, smoking, drinking frequency, drinking glasses/occasions, and physical activity at work and in leisure time. Adjusted ORs were then calculated with all variables included. A sensitivity analysis was performed where participants who used drugs associated with IBS were excluded [30]. Values are given as numbers and percentages, median and interquartile ranges, or OR and 95% CI. P < 0.05 was considered significant.

Results

Study population

Of the 5,277 participants enrolled in the MOS, only the 2,200 women with information from the National Board of Health and Welfare were included in this project (Fig. 1). Of the included women, 72 participants had an endometriosis diagnosis, and 61 (84.7%) of them had answered the questions about self-reported IBS. Of these women, 21 (34.4%) had self-reported IBS. Only 22 participants (36.1%) had answered the VAS-IBS questionnaire, and only 2 of them were without any gastrointestinal symptoms at all.

Fig. 1
figure 1

Study population. Flow chart showing the origin of the participants, including excluded individuals and groupings. IBS: irritable bowel syndrome

Full size image

Of the 1,915 participants who had answered the question if they have IBS or not, 436 participants (22.8%) had self-reported IBS. Two of them had not answered the questions about gastrointestinal symptoms. Of the remaining 434 participants, 319 (73.2%) had at least one gastrointestinal symptom (Fig. 1). There was an association between self-reported IBS and IBS diagnoses from the medical records (p < 0.001).

Endometriosis

The women with endometriosis had a median age of 52.6 years (range 19.6–69.6 years), compared with a median age of 43.3 years (range 18.3–72.9 years) in those without the diagnosis. Participants with endometriosis had a median BMI of 24.6 kg/m2 (range 19.0–41.4 kg/m2) and those without endometriosis had a median BMI of 24.3 kg/m2 (range 15.4–50.1 kg/m2).

In the crude calculations, endometriosis was associated with the age groups 40–49 years (OR: 3.60; 95% CI: 1.38–9.55; p = 0.010), 50–59 years (OR: 6.32; 95% CI: 2.63–15.17; p < 0.001), and ≥ 60 years (OR: 5.61; 95% CI: 2.13–14.76; p < 0.001), and sick leave (OR: 2.94; 95% CI: 1.46–5.92; p = 0.002), and inversely associated with moderate (OR: 0.44; 95% CI: 0.20–0.97; p = 0.042) and regularly exerted (OR: 0.35; 95% CI: 0.14–0.89; p = 0.027) physical activity in leisure time (Table 1).

Table 1 Characteristics of the endometriosis population
Full size table

In the adjusted model, there was a significant association between endometriosis and the age groups 50–59 years (OR: 6.92; 95% CI: 1.97–24.32; p = 0.003) and ≥ 60 years (OR: 6.27; 95% CI: 1.56–25.17; p = 0.010), sick leave (OR: 2.43; 95% CI: 1.08–5.48; p = 0.033), and former smoking (OR: 3.02; 95% CI: 1.19–7.68; p = 0.020). There was also an inverse association between endometriosis and BMI > 30 kg/m2 (OR: 0.36; 95% CI: 0.14–0.91; p = 0.031). No significant associations were found between endometriosis and education, marital status, drinking frequency, drinking amount, and physical activity at work and in leisure time in the adjusted model (Table 1).

There was an association between endometriosis and self-reported IBS when adjusted for age, BMI, occupation, and smoking as cofounders (OR: 1.86; 95% CI: 1.06–3.261; p = 0.029).

Irritable bowel syndrome

The participants with self-reported IBS had a median age of 42.0 years (range 18.5–70.0 years), and the women without self-reported IBS had a median age of 45.4 years (range 18.4–72.9 years). The median BMI of the women with self-reported IBS was 24.2 kg/m2 (range 16.6–50.1 kg/m2), and those without self-reported IBS had a median BMI of 24.3 kg/m2 (range 15.9–50.1 kg/m2) (Table 2).

Table 2 Characteristics of the IBS population
Full size table

In crude calculations, self-reported IBS was associated with sick leave (OR: 1.90; 95% CI: 1.30–2.79; p < 0.001) and former smoking (OR: 1.39; 95% CI: 1.03–1.86; p = 0.029), and inversely associated with the ages 50–59 years (OR: 0.74; 95% CI: 0.53–0.99; p = 0.043), a drinking frequency of 2–4 times/month (OR: 0.72; 95% CI: 0.57–0.93; p = 0.010) and 2–3 times/week (OR: 0.68; 95% CI: 0.51–0.92; p = 0.009), and moderate but regularly (OR: 0.63; 95% CI: 0.42–0.94; p = 0.026) and regularly exerted (OR: 0.64; 95% CI: 0.42–0.98; p = 0.041) physical activity in leisure time (Table 2).

After adjustment for all variables, there was a significant association between self-reported IBS and sick leave (OR: 1.77; 95% CI: 1.14–2.73; p = 0.010), and a tendency to association with present smoking (OR: 1.30; 95% CI: 0.98–1.72; p = 0.071) (Table 2).

There was an association between self-reported IBS and endometriosis when adjusted for occupation and smoking (OR: 1.77; 95% CI: 1.02–3.07; p = 0.041).

In the sensitivity analysis, self-reported IBS was inversely associated with the age groups 50–59 years (OR: 0.62; 95% CI: 0.45–0.85; p = 0.003) and ≥ 60 years (OR: 0.65; 95% CI: 0.43–0.98; p = 0.040), and with a drinking frequency of 2–4 times/month (OR: 0.73; 95% CI: 0.56–0.95; p = 0.021) and 2–3 times/week (OR: 0.72; 95% CI: 0.52–0.98; p = 0.038). After adjustment, self-reported IBS was inversely associated with the ages 50–59 years (OR: 0.58; 95% CI: 0.38–0.90; p = 0.015) and positively associated with present smoking (OR: 1.39; 95% CI: 1.03–1.89; p = 0.033) (Table 3). No significant associations were found between self-reported IBS and BMI, education, marital status, drinking frequency, drinking amount, and physical activity at work and in leisure time after adjustment for confounders (Tables 2 and 3).

Table 3 IBS population with drug use participants excluded
Full size table

Gastrointestinal symptoms

A comparison of the gastrointestinal symptoms was made between women with endometriosis, women with self-reported IBS, women with both endometriosis and self-reported IBS, and healthy women. There was a significant difference in pain, diarrhea, constipation, bloating/gases, intestinal symptoms’ influence on daily life, and psychological well-being (p < 0.001) between groups, with a tendency to differences in vomiting and nausea (p = 0.051). Significant differences were observed between healthy participants and self-reported IBS regarding abdominal pain, diarrhea, constipation, intestinal symptoms’ influence on daily life, and psychological well-being (p < 0.001 for all), and vomiting and nausea (p = 0.016). There was also a significant difference in abdominal pain (p = 0.004), constipation (p = 0.018), bloating/gases (p = 0.026), intestinal symptoms’ influence on daily life (p = 0.008), and psychological well-being (p = 0.002) between healthy vs. endometriosis and self-reported IBS (Table 4). There were no differences between endometriosis and IBS regarding abdominal pain (p = 0.116), diarrhea (p = 0.320), constipation (p = 0.306), bloating and flatulence (p = 0.395), vomiting and nausea (p = 0.219), the intestinal symptoms’ influence on daily life (p = 0.527), and psychological well-being (p = 0.092).

Table 4 Gastrointestinal symptoms of the study population
Full size table

Discussion

The main findings of the present study based on a population cohort were that endometriosis and IBS were associated with each other. Endometriosis was associated with higher age, sick leave, and former smoking, whereas there was an inverse association with BMI. Further, self-reported IBS was associated with sick leave, with a tendency towards an association with present smoking. When excluding participants using drugs associated with IBS [30], self-reported IBS was inversely associated with age and positively associated with smoking. There was a difference in gastrointestinal symptoms between women with IBS and healthy participants, but no significant differences were found among women with endometriosis compared to women with IBS or healthy participants.

Endometriosis is diagnosed at all levels of health care [31]. This project, however, only used information from specialized inpatient and outpatient care, which might have resulted in the lower prevalence of endometriosis compared to other studies [4], with a slightly higher age [13].

The observed association between endometriosis and IBS is in line with three systematic reviews which all observed a two- to threefold risk of getting an IBS diagnosis if the women had endometriosis [9, 10, 17]. In two reviews an increased risk was observed to get an endometriosis diagnosis if the women also had a history of IBS [9, 17]. When no organic changes are found in patients complaining of gastrointestinal symptoms, the IBS diagnosis is used. Due to similar symptoms, the diagnostic delay of endometriosis may be up to 7 years [32]. To resolve this problem, a new algorithm for endometriosis diagnosis has recently been developed and published [33].

The associations noted between the two diseases may be casual or may be based on sharing the same background encompassing chronic inflammatory visceral hypersensitivity [9, 10]. Numerous endometriosis patients have undergone surgical procedures, as could also be the truth for patients with diffuse abdominal pain later called IBS. Laparoscopic procedures or other surgery may in some cases lead to development of visceral hypersensitivity, further triggering pain experience and obscuring the difference between endometriosis and IBS [34]. The association between endometriosis and IBS may also exist due to their common risk factors; being a woman under the age of 50 years [6, 13, 14].

Around half of the endometriosis patients could differentiate between symptoms from endometriosis and symptoms from the gastrointestinal tract [23]. The median duration of gastrointestinal symptoms was 5 months shorter than for other symptoms of endometriosis, although the gastrointestinal symptoms may be the first symptoms in some endometriosis patients. Several cases had received the IBS diagnosis before endometriosis [17, 23]. If young women present with varying symptoms from internal organs, the physician´s specialty has great impact on which diagnosis is given, since the training in considering other options than the own field is limited.

An inverse association between endometriosis and BMI was observed, which is in line with previous research [18, 35]. Association between endometriosis and sick leave and smoking are in line with a larger study cohort with selected endometriosis patients, where the same tendency was observed although not statistically significant [18]. In contrast, others have not observed associations between endometriosis and smoking [36].

Endometriosis is thought to be an inflammatory-driven disease [37]. Physical activity is thought to increase levels of anti-inflammatory cytokines [38]. Therefore, physical activity might have an inverse association with endometriosis. Accordingly, Ek et al. [18] found an inverse association between endometriosis and physical activity; an association which disappeared in the current study after adjustment for cofounders. A systematic review indicated an inverse association with physical activity but concluded that more studies are needed [38]. It should be considered that the inverse association between physical exercise and endometriosis might be due to that pain prevents the women from exercising.

Endometriosis is an estrogen-dependent disease [11], and previous studies have observed an association between estrogen-dependent diseases and alcohol [39]. Therefore, alcohol intake should be associated with endometriosis. Some studies have described such an association between endometriosis and alcohol intake [35, 40], whereas studies from our region point in the opposite direction [18]. The inverse association between endometriosis and alcohol consumption might not reflect causality.

Since the IBS diagnoses were self-reported, there could be a misreporting of the diagnosis from the participants. However, the significant association between self-reported IBS and IBS diagnosis from medical records suggests a small risk of misreporting. The present association between IBS and sick leave was a non-significant trend in the former, smaller MOS cohort [19]. The sensitivity analyses observed a positive association between IBS and smoking and an inverse association with age in line with previous research [19], although there are conflicting results among studies [41]. Other studies have also observed an association between abdominal and general pain and smoking [42, 43].

This population-based study did not observe any significant difference in the symptoms between women with endometriosis and IBS, which is in line with current research where women with endometriosis may fulfill the Rome criteria [9, 10, 17]. However, the symptoms were aggravated in IBS, especially pain, diarrhea, constipation, and bloating. The cohorts recruited from a tertiary center described symptom differences between the two entities [22], which underlines the importance of studying different cohorts. Both endometriosis and IBS were associated with sick leave, supporting the great impact of the diseases on quality of life [18, 44, 45]. When symptoms were related to endometriosis location, cyclic defecation pain, cyclic constipation, and longer stool evacuation time were more frequently found in rectal endometriosis compared to other locations [46]. Another study showed that deeply infiltrating endometriosis (DIE) in varying organs affected the symptoms, and DIE involving the bowel was associated with more frequent noncyclic pain and overall gastrointestinal pain [47]. Since the localization of endometriosis was not known in the current study, no such comparisons could be made.

This cross-sectional study from a population-based cohort might entail a more representative selection of people than a study enrolling participants with a specific diagnosis. Enrollment of a population-based cohort and a specific cohort from a tertiary center from the same region is a strength and made it possible to compare the same diseases at several levels. Other strengths of this survey are the use of validated questions about specific gastrointestinal symptoms and exclusion of drugs associated with IBS [26, 30]. However, there is a risk of selection bias with more well-educated and health-conscious participants in clinical studies, thus, not truly representing the general population. Furthermore. there is also a risk of recall bias with the selection of study participants to MOS from MDCS-CC. The main limitation of the present study was that it did not include participants with a diagnosis given at primary healthcare centers, which could possibly contribute to a small endometriosis group. A small group means higher risks of bias and inaccuracy in results. Furthermore, many participants did not answer the VAS-IBS. The information about endometriosis was taken from the National Patient Register, and did not include the mode of diagnosis, the localization and severity of the disease, or the treatment given. Thus, some of the endometriosis patients may not have been investigated by laparoscopy [3, 5], and the symptoms could not be adjusted for subgroups of endometriosis. Another weakness of the study was that the healthy comparison group did not exclude participants with other diseases that cause gastrointestinal symptoms, which caused higher VAS-IBS scores in the healthy group compared to the healthy female reference group without any diseases [27]. Assessing the gastrointestinal symptoms during the past 2 weeks is a limitation because of the risk of excluding symptoms from the past.

Conclusion

In conclusion, endometriosis and IBS were associated. Whether the association is causal or depends on common risk factors or common pathogenesis could not be determined. No obvious difference in gastrointestinal symptoms was observed between the two conditions, thus making it difficult to clinically distinguish between the diagnoses from the gastrointestinal viewpoint. The question remains whether women with endometriosis are wrongly diagnosed with IBS or whether they suffer from both IBS and endometriosis. Additional and larger studies in this area are needed to differentiate between the diagnoses to be able to give the most optimal treatment to women with gastrointestinal symptoms.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ATC-system:

Anatomic therapeutic chemical classification system

BMI:

Body mass index

CI:

Confidence interval

DGBI:

Disease of the gut-brain interaction

FASS:

Farmaceutiska specialiteter i Sverige

FODMAP:

Fermentable oligo-, di-, monosaccharides and polyols

IBS:

Irritable bowel syndrome

MDCS-CC:

Malmö Diet Cancer Study-Cardiovascular Cohort

MOS:

Malmö Offspring Study

OR:

Odds ratio

VAS-IBS:

Visual analog scale for irritable bowel syndrome

WHO:

World Health Organization

References

  1. Bedaiwy MA, Alfaraj S, Yong P, Casper R. New developments in the medical treatment of endometriosis. Fertil Steril. 2017;107(3):555–65.

    Article  CAS  PubMed  Google Scholar 

  2. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;2014(3):Cd009590.

    PubMed  PubMed Central  Google Scholar 

  3. Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):Cd012179.

    PubMed  PubMed Central  Google Scholar 

  4. Giudice LC, Kao LC, Endometriosis. Lancet (Lond Engl). 2004;364(9447):1789–99.

    Article  Google Scholar 

  5. Hickey M, Ballard K, Farquhar C, Endometriosis. BMJ. 2014;348:g1752.

    Article  PubMed  Google Scholar 

  6. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–17.

    Article  PubMed  Google Scholar 

  7. Shivaji UN, Ford AC. Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic. Frontline Gastroenterol. 2014;5(4):266–71.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150:1393–407.

    Article  Google Scholar 

  9. Chiaffarino F, Cipriani S, Ricci E, Mauri PA, Esposito G, Barretta M, et al. Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(1):17–25.

    Article  PubMed  Google Scholar 

  10. Nabi MY, Nauhria S, Reel M, Londono S, Vasireddi A, Elmiry M, et al. Endometriosis and irritable bowel syndrome: a systematic review and meta-analyses. Front Med (Lausanne). 2022;9:914356.

    Article  PubMed  Google Scholar 

  11. Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Res. 2016;5.

  12. Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol. 2017;57(2):201–5.

    Article  PubMed  Google Scholar 

  13. Eisenberg VH, Weil C, Chodick G, Shalev V. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG. 2018;125(1):55–62.

    Article  CAS  PubMed  Google Scholar 

  14. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–21e4.

    Article  PubMed  Google Scholar 

  15. Sibelli A, Chalder T, Everitt H, Workman P, Windgassen S, Moss-Morris. R.A systematic review with meta-anaysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med. 2016;46(15):3065–80.

    Article  CAS  PubMed  Google Scholar 

  16. McGrath IM, Montgomery GW, Mortlock S. Insights from mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities. Hum Reprod Update. 2023:dmad009.

  17. Saidi K, Sharma S, Ohlsson B. A systematic review and meta-analysis of the associations between endometriosis and irritable bowel syndrome. Eur J Obstet Gynecol Reprod Biol. 2020;246:99–105.

    Article  PubMed  Google Scholar 

  18. Ek M, Roth B, Nilsson PM, Ohlsson B. Characteristics of endometriosis: a case-cohort study showing elevated IgG titers against the TSH receptor (TRAb) and mental comorbidity. Eur J Obstet Gynecol Reprod Biol. 2018;231:8–14.

    Article  CAS  PubMed  Google Scholar 

  19. Nilsson D, Ohlsson B. Gastrointestinal symptoms and irritable bowel syndrome are Associated with Female Sex and Smoking in the General Population and with unemployment in men. Front Med (Lausanne). 2021;8:646658.

    Article  PubMed  Google Scholar 

  20. Parasar P, Ozcan P, Terry KL, Endometriosis. Epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 2017;6(1):34–41.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. Cochrane Database Syst Rev. 2014(3):Cd008797.

  22. Ek M, Roth B, Bengtsson M, Ohlsson B. Gastrointestinal symptoms in women with endometriosis and microscopic colitis in comparison to irritable bowel syndrome: a cross-sectional study. Turk J Gastroenterol. 2021;32(10):819–27.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ek M, Roth B, Ekström P, Valentin L, Bengtsson M, Ohlsson B. Gastrointestinal symptoms among endometriosis patients–A case-cohort study. BMC Womens Health. 2015;13:15:59.

    Article  Google Scholar 

  24. Brunkwall L, Jonsson D, Ericson U, Hellstrand S, Kennback C, Ostling G, et al. The Malmo offspring study (MOS): design, methods and first results. Eur J Epidemiol. 2021;36(1):103–16.

    Article  PubMed  Google Scholar 

  25. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.

    Article  PubMed  Google Scholar 

  26. Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the Visual Analogue Scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2007;7:16.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii.

    Google Scholar 

  29. WHO collaborating center for drug ststistics methodology. ATC/DDD Index 2022 [Internet]. Norwegian institute of public helath; 2021 [updated 2021-12-14; cited 2022-10-24. Available from: https://www.whocc.no/atc_ddd_index/.

  30. Ruderstam H, Ohlsson B. Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases. Scand J Gastroenterol. 2022;1–11. https://doi.org/10.1080/00365521.2022.2031281.

  31. Pugsley Z, Ballard K. Management of endometriosis in general practice: the pathway to diagnosis. Br J Gen Pract. 2007;57(539):470–6.

    PubMed  PubMed Central  Google Scholar 

  32. Wróbel M, Wielgoś M, Laudański P. Diagnostic delay of endometriosis in adults and adolescence-current stage of knowledge. Adv Med Sci. 2022;67(1):148–53.

    Article  PubMed  Google Scholar 

  33. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220:354e1–12.

    Article  Google Scholar 

  34. Blichfeldt-Eckhardt MR, Ording H, Andersen C, Licht PB, Toft P. Early visceral pain predicts chronic pain after laparoscopic cholecystectomy. Pain. 2014;155(11):2400–7.

    Article  PubMed  Google Scholar 

  35. Zhang Y, Ma NY. Environmental risk factors for endometriosis: an Umbrella Review of a Meta-analysis of 354 observational studies with over 5 million populations. Front Med (Lausanne). 2021;8:680833.

    Article  PubMed  Google Scholar 

  36. Bravi F, Parazzini F, Cipriani S, Chiaffarino F, Ricci E, Chiantera V, et al. Tobacco smoking and risk of endometriosis: a systematic review and meta-analysis. BMJ Open. 2014;4(12):e006325.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory Mediators and Pain in Endometriosis: a systematic review. Biomedicines. 2021;9(1):54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bonocher CM, Montenegro ML, Rosa ESJC, Ferriani RA, Meola J. Endometriosis and physical exercises: a systematic review. Reprod Biol Endocrinol. 2014;12:4.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001;286(17):2143–51.

    Article  CAS  PubMed  Google Scholar 

  40. Parazzini F, Cipriani S, Bravi F, Pelucchi C, Chiaffarino F, Ricci E, et al. A metaanalysis on alcohol consumption and risk of endometriosis. Am J Obstet Gynecol. 2013;209(2):106e1–10.

    Article  Google Scholar 

  41. Creed F. Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment Pharmacol Ther. 2019;50(5):507–16.

    Article  PubMed  Google Scholar 

  42. Pisinger C, Aadahl M, Toft U, Birke H, Zytphen-Adeler J, Jørgensen T. The association between active and passive smoking and frequent pain in a general population. Eur J Pain. 2011;15(1):77–83.

    Article  PubMed  Google Scholar 

  43. Zia JK, Lenhart A, Yang PL, Heitkemper MM, Baker J, Keefer L, et al. Risk factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in adults and children: a systematic review. Gastroenterology. 2022;163(4):995–1023e3.

    Article  PubMed  Google Scholar 

  44. Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and Meta-analysis. Gastroenterology. 2017;152(5):1042–54e1.

    Article  PubMed  Google Scholar 

  45. Shah E, Rezaie A, Riddle M, Pimentel M. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol. 2014;27(3):224–30.

    PubMed  PubMed Central  Google Scholar 

  46. Roman H, Ness J, Suciu N, Bridoux V, Gourcerol G, Leroi AM, et al. Are digestive symptoms in women presenting with pelvic endometriosis specific to lesion localizations? A preliminary prospective study. Hum Reprod. 2012;27(12):3440–9.

    Article  PubMed  Google Scholar 

  47. Fauconnier A, Chapron C, Dubuisson JB, Vieira M, Dousset B, Breart G. Relation between pain symptoms. and the anatomic location of deep infiltrating endometriosis. Fertil Steril. 2002;78(4):719–26.

Download references

Acknowledgements

Thanks to Anders Dahlin for data management.

Funding

The study was supported by grants from the Development Foundation of Region Skåne.

Open access funding provided by Lund University.

Author information

Authors and Affiliations

  1. Department of Clinical Science, Lund University, Malmö, Sweden

    Sofie Stark Junkka & Bodil Ohlsson

  2. Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden

    Bodil Ohlsson

Authors
  1. Sofie Stark Junkka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bodil Ohlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BO were responsible for the study design and both authors were responsible for statistical analysis, interpretation of the participants’ data. SSJ wrote the initial draft and both authors approved the final manuscript.

Corresponding author

Correspondence to Bodil Ohlsson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study had ethical approval from the Regional Ethics committee in Lund, 2012/594 and the study participants were treated according to the Declaration of Helsinki. Written informed consent was obtained from all participants to participate in the study prior inclusion.

Consent for publication

Not Applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Junkka, S.S., Ohlsson, B. Associations and gastrointestinal symptoms in women with endometriosis in comparison to women with irritable bowel syndrome: a study based on a population cohort. BMC Gastroenterol 23, 228 (2023). https://doi.org/10.1186/s12876-023-02861-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12876-023-02861-w

Keywords

BMC Gastroenterology

ISSN: 1471-230X

Contact us